Curemark, LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, recently hosted New York Senator Kirsten Gillibrand as she announced a new proposal to spur innovation and job creation, locally and nationally. Speaking at Curemark, which is developing an autism treatment, Senator Gillibrand detailed a new proposal to expand, simplify and make permanent the Research and Development tax credit.
More than 2,000 New York companies could take advantage of the R&D credit, ...
read more